Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Researchers at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, are improving rapid and accurate model development for infectious and complex diseases.
Timely, high-quality data is critical to reaching the United Nations Sustainable Development Goals — but harnessing it requires new ways of thinking, collaboration, and investment in national statistics systems.
Since finding that microRNA is also present outside cells, a team from Nanjing University in China has made key contributions to the field of extracellular RNA, and has opened a path to new diagnostic and therapeutic potential.
By bringing together the worlds of histology and sequencing, spatial genomic analysis allows researchers to study the tumour microenvironment in situ and understand the influence of immune cells on cancer progression.
Producing therapeutic antibodies is expensive and difficult, but drug-makers have unprecedented flexibility in plant design through a new modular biologics manufacturing platform that streamlines the process.
Novadip is designing new treatment options for critical size defects, complex small size defects and surgically inaccessible tissue with its patented 3D tissue regeneration technology platform to transform the lives of patients with unmet medical needs.
Randall Platt is the 2020 Eppendorf Young European Investigator. He is an assistant professor in both the Department of Biosystems Science and Engineering at ETH Zurich, and the Department of Chemistry at the University of Basel. Here he talks to science writer Geoff Marsh about his award-winning work on creating a ‘molecular recorder’.
As part of the effort to better understand complex traits and diseases, researchers are finding that combining different omics readouts, taken simultaneously, offers advantages over conducting separate analyses.
Accelerating the drug discovery and development process, Bioelectronica has developed Hypercell, a digital biochemistry integrated single-cell identification and sorting system offering superior output.
Using next-generation sequencing tools, scientists are exploring how SARS-CoV-2 interacts with the immune system to better understand the disease, identify those at higher risk, and minimize its impact.
Engine Biosciences has developed a multi-layered platform, NetMAPPR, which integrates machine learning and combinatorial CRISPR to decode biological networks, pinpoint crucial units, and design specific therapeutics.